1-7 of 7
Rolf M Mesters, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Christoph Schliemann, MD, Katrin Gutbrodt, PhD, Andrea Kerkhoff, MD, Michele Pohlen, MD, Stefanie Wiebe, MD, Gerda Silling, MD, Linus Angenendt, Torsten Kessler, MD, Rolf M Mesters, MD, Leonardo Giovannoni, PhD, Michael Schäfers, MD, Bianca Altvater, PhD, Claudia Rössig, MD, Inga Grünewald, MD, Eva Wardelmann, MD, Gabriele Köhler, MD, Dario Neri, PhD, Matthias Stelljes, MD, Wolfgang E Berdel, MD
Journal: Blood
Blood (2014) 124 (21): 980.
https://doi.org/10.1182/blood.V124.21.980.980
Published: 2014
Journal Articles

Impact of SERPINC1, PROC and PROS1 Mutations on the Thrombotic Phenotype in Children with Venous Thromboembolism: An Observational Multicenter Cohort Study

Verena Limperger, Gili Kenet, MD, Christine Heller, MD, Karin Kurnik, Ralf Knoefler, Rolf M Mesters, MD, Susan Halimeh, MD, Ulrike Nowak-Göttl
Journal: Blood
Blood (2014) 124 (21): 583.
https://doi.org/10.1182/blood.V124.21.583.583
Published: 2014
Journal Articles

Acute Myeloid Leukemia: The Outcome Is Determined By Age, Genetic Group, White Blood Cell Count, Lactate Dehydrogenase, Rather Than By Chemotherapy Intensity

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Utz Krug, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Carsten Mueller-Tidow, MD, Matthias Stelljes, MD, Rolf M. Mesters, MD, Hubert Serve, MD, Jan Braess, MD, Karsten Spiekermann, MD, Peter Staib, MD, Andreas Grueneisen, MD, Albrecht Reichle, MD, Leopold Balleisen, MD, Hartmut Eimermacher, MD, Aristoteles Giagounidis, MD, PhD, Herbert Rasche, MD, Eva Lengfelder, M.D. Ph.D., Andreas Faldum, MD, Maria Cristina Sauerland, MSc, Achim Heinecke, PhD, Rüdiger Hehlmann, MD, Bernhard J. Woermann, MD, Wolfgang Hiddemann, MD
Journal: Blood
Blood (2013) 122 (21): 1447.
https://doi.org/10.1182/blood.V122.21.1447.1447
Published: 2013
Journal Articles

Targeting Interleukin-2 to the Neovasculature Potentiates Rituximab‘s Activity Against Mantle Cell Lymphoma in Mice

Christoph Schliemann, MD, Niklas Börschel, Christian Schwöppe, PhD, Rüdiger Liersch, MD, Torsten Kessler, MD, Martin Dreyling, Wolfram Klapper, MD, Hans D. Menssen, MD, Dario Neri, PhD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD
Journal: Blood
Blood (2012) 120 (21): 3716.
https://doi.org/10.1182/blood.V120.21.3716.3716
Published: 2012
Journal Articles

Expression of Angiopoietins and Their Receptor Tie2 in the Bone Marrow of Patients with Acute Myeloid Leukemia.

Christoph Schliemann, MD, Ralf Bieker, MD, Teresa Padro, MD, Torsten Kessler, MD, Heike Hintelmann, Thomas Buchner, MD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD
Journal: Blood
Blood (2006) 108 (11): 1894.
https://doi.org/10.1182/blood.V108.11.1894.1894
Published: 2006
Journal Articles

Bevacizumab Reduces VEGF Expression in Patients with Relapsed and/or Refractory Acute Myeloid Leukaemia (AML) without Clinical Antileukemic Activity.

Lejla Zahiragic, MD, Christoph Schliemann, MD, Ralf Bieker, MD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD
Journal: Blood
Blood (2006) 108 (11): 4543.
https://doi.org/10.1182/blood.V108.11.4543.4543
Published: 2006
Journal Articles

Inhibition of Tumor Growth by RGD Peptide Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature.

Torsten Kessler, MD, Ralf Bieker, MD, Teresa Padro, PhD, Federico Herrera, MD, Sandra Ruiz, MD, Hubert Serve, MD, Micheal Kreuter, MD, Wolfgang E. Berdel, MD, Rolf M. Mesters, MD
Journal: Blood
Blood (2004) 104 (11): 1934.
https://doi.org/10.1182/blood.V104.11.1934.1934
Published: 2004